Reid Hoffman is stepping down from Microsoft’s board after a decade, ready to return to founder mode with his new AI-driven biotech startup, Manus. Once the architect behind LinkedIn’s $26.2 billion sale to Microsoft, Hoffman now co-leads Manus — focused on revolutionizing drug discovery with “Move 37” AI — aiming to unlock breakthroughs in cancer treatment. With over $50 million in funding and Dr. Siddhartha Mukherjee at the helm as CEO, Hoffman is fully immersed, channeling his deep tech and AI expertise to fuel innovation where it matters most.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/b73459dad5fd096a

Podden och tillhörande omslagsbild på den här sidan tillhör The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av, eller tillsammans med, Poddtoppen.